Toftegaard-Nielsen, T.

3 years patient revascularization 1 year surgery stenting ⅐⅐⅐ angioplasty trial swets subs service stent outcome group event study revascularization therapy study artery treatment disease circulation predictor quality table result cost-effectiveness point efficacy end point survival balloon angioplasty event-free diabetes balloon follow-up percutaneou service randomized coll cardiol event-free patient 19 257 € multivessel february randomised intervention treatment infarction procedure intervention downloaded method end point difference death circ.ahajournals.org status stenosi macce cardiol 0–3 0–1 therapy serruy investigation event-free survival analysis queiroz e melo variable 3- year events randomized comparison percutaneous transluminal stroke angioplasty revascularization investigation revascularization procedures torsten toftegaard nielsen efficacy stent deployment 142 391 € jos é p 10 492 € estimate eq -5d revascularization investigation 1- year follow-up